Condor Software, Inc.
Every year, hundreds of billions of dollars are invested to discover and develop new therapies, yet the financial infrastructure behind that work has not kept pace. Clinical operations and finance live in disconnected worlds, forcing teams to make high-stakes decisions using fragmented tools and static data. Condor exists to change that. We are a system of action, building the financial intelligence layer that will power the next era of clinical development. Condor connects clinical operations, vendor activity, and financial signals into a single, real-time intelligence layer, giving R&D and finance leaders true command over how their organizations operate. Condor is pharma-native, AI-driven infrastructure built to scale industry standards we helped define with Big 4 partners. It powers prediction, control, and execution across the most complex R&D environments in the world. Why This Matters Now Condor has moved past proving the concept. Enterprise teams already trust Condor to run critical operations and finance. The work ahead is the hardest part: scaling something people depend on when the stakes are this high. Condor is a high-growth Series A company backed by top institutional partners like Insight Partners, Felicis, and 645 Ventures, growing rapidly with Top 200 biopharma companies. This is a rare opportunity to help build foundational infrastructure that will shape how new therapies reach patients.